IRIS
FRANCESCHINI, ROSSELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.932
EU - Europa 5.494
AS - Asia 2.547
SA - Sud America 479
AF - Africa 144
Continente sconosciuto - Info sul continente non disponibili 121
OC - Oceania 12
Totale 15.729
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.859
GB - Regno Unito 1.598
CN - Cina 926
RU - Federazione Russa 868
IT - Italia 806
SG - Singapore 743
IE - Irlanda 627
UA - Ucraina 406
BR - Brasile 401
SE - Svezia 348
FR - Francia 272
DE - Germania 260
VN - Vietnam 260
HK - Hong Kong 209
FI - Finlandia 154
KR - Corea 104
ZA - Sudafrica 73
IN - India 63
BD - Bangladesh 48
TR - Turchia 48
CA - Canada 47
ES - Italia 28
BE - Belgio 27
IQ - Iraq 26
PL - Polonia 25
AR - Argentina 21
NL - Olanda 18
NG - Nigeria 16
JP - Giappone 15
CO - Colombia 14
ID - Indonesia 14
MX - Messico 14
CZ - Repubblica Ceca 13
SA - Arabia Saudita 13
AU - Australia 11
EC - Ecuador 11
KE - Kenya 11
MY - Malesia 11
CI - Costa d'Avorio 9
CL - Cile 9
AT - Austria 8
UZ - Uzbekistan 8
MA - Marocco 7
NP - Nepal 7
PK - Pakistan 7
VE - Venezuela 7
EG - Egitto 6
PH - Filippine 6
EU - Europa 5
JM - Giamaica 5
JO - Giordania 5
LY - Libia 5
PY - Paraguay 5
BG - Bulgaria 4
CH - Svizzera 4
DZ - Algeria 4
IR - Iran 4
KZ - Kazakistan 4
LB - Libano 4
LV - Lettonia 4
PE - Perù 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
GR - Grecia 3
HR - Croazia 3
PT - Portogallo 3
RO - Romania 3
SN - Senegal 3
TH - Thailandia 3
AO - Angola 2
AZ - Azerbaigian 2
DK - Danimarca 2
EE - Estonia 2
GE - Georgia 2
LK - Sri Lanka 2
LT - Lituania 2
OM - Oman 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CR - Costa Rica 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
NI - Nicaragua 1
Totale 15.608
Salva come PNG Salva come JPEG
Città #
Southend 1.500
Dallas 787
Dublin 625
Ashburn 567
Fairfield 564
Menlo Park 445
Singapore 407
Jacksonville 335
Chandler 318
Santa Clara 312
San Jose 307
Woodbridge 259
Beijing 251
Moscow 249
Houston 214
Wilmington 214
Milan 206
Seattle 200
Hong Kong 198
Cambridge 190
Ann Arbor 172
New York 140
Council Bluffs 125
Princeton 117
The Dalles 113
Siena 109
Seoul 104
Nanjing 103
Los Angeles 88
Hefei 83
Helsinki 78
Rome 78
Hanoi 73
Ho Chi Minh City 73
Johannesburg 65
Lauterbourg 61
Munich 50
Boardman 49
Nanchang 48
Bar Harbor 40
Dearborn 39
San Diego 37
Buffalo 36
Columbus 36
San Mateo 35
São Paulo 33
Hebei 28
Izmir 28
Shenyang 28
San Francisco 25
London 23
Brussels 21
Orem 21
Changsha 20
Jinan 20
Kunming 20
Washington 20
Shanghai 19
Turku 19
Düsseldorf 18
Toronto 18
Boston 17
Málaga 17
Rio de Janeiro 16
Warsaw 16
Abuja 15
Frankfurt am Main 15
Bologna 14
Montreal 14
Redondo Beach 14
Tianjin 14
Tokyo 14
Turin 14
Chicago 13
Florence 13
Jiaxing 13
Brooklyn 12
Da Nang 12
Guangzhou 12
Belo Horizonte 11
Norwalk 11
Redwood City 11
Atlanta 10
Campinas 10
Dhaka 10
Dong Ket 10
Haiphong 10
Naples 10
Abidjan 9
Bengaluru 9
Charlotte 9
Kraków 9
Manchester 9
Nairobi 9
Brasília 8
Brno 8
Chennai 8
Hangzhou 8
Poplar 8
Taizhou 8
Totale 10.911
Salva come PNG Salva come JPEG
Nome #
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 359
A novel OPA1 mutation in a family with Autosomal Dominant Optic Atrophy 348
A novel mutation producing premature termination codon at the OPA1 gene causes autosomal dominant optic atrophy. 334
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 325
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 322
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 322
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 321
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 300
Genotype-phenotype and OCT correlations in Autosomal Dominant Optic Atrophy related to OPA1 gene mutations: Report of 13 Italian families 295
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 282
Cavernous malformation of the optic nerve mimicking optic neuritis 278
A difficult case: sarcoidosis with CNS involvement or sarcoidosis associated with multiple sclerosis? 272
Aspetti angiografici con verde di indocianina in alcune patologie oculari 267
Uveiti Infantili : incidenza delle varie forme e correlazione con le malattie sistemiche 265
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 265
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 263
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 260
Molecular genetic study of Leber’s hereditary optic neurophaty (LHON): mutation screening by sequencing of ND1, ND4, ND%, ND6 genes 251
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 249
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 247
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 246
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 245
Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene 242
Optic perineuritis: A further cause of visual loss and disc edema in children 242
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 241
A new Krit1 gene mutation in a family with cerebral cavernous malformation (CCM) associated with intraorbital optic nerve and cutaneous cavernous angiomas 240
Leber's hereditary optic neuropathy associated with cocaine, ecstasy and telithromycin consumption 234
IL-6 blockade in the management of non-infectious uveitis 233
Citologia congiuntivale dei portatori di lenti a contatto morbide 226
Pseudoistoplasmosi oculare da Candida: descrizione di un caso clinico 224
In vivo confocal microscopy and anterior segment optical coherence tomography in a case of alternaria keratitis 224
Leber's hereditary optic neuropathy associated with cocaine, ecstasy and telythromicin consumption 221
Atrofie ottiche " asintomatiche" della prima infanzia: difficoltà interpretative 214
Subcortical low-intensity and restricted diffusion after first seizure in a child 211
Descrizione di una nuova mutazione del gene Krit1 in una forma familiare di angioma cavernoso cerebrale associata ad angioma ottico e ad angioma cutaneo 206
Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behçet's Disease: A Case Series 205
The protean ocular involvement in monogenic autoinflammatory diseases: state of the art 204
The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases 204
Uveiti prevalentemente posteriori ed entità cliniche di incerta definizione 198
Vasculopatia occlusiva retinica in paziente con emoglobina SC 192
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study 192
Human herpesvirus-6B active infection associated with relapsing bilateral anterior optic neuritis 187
Influenza della flogosi oculare sulla concentrazione della sisomicina nell'umore acqueo di coniglio 186
Irido-corneal-endothelial syndrome: a confocal and anterior segment coherent tomography differential diagnosis 184
Esoftalmo da flogosi 182
Anakinra treatment in drug-resistant Behcet's disease: a case series. 181
Serum amyloid-A in Behçet's disease 181
Esame con PCR sul vitreo per la diagnosi di retinite da CMV 171
Indicazioni e valutazione degli esami infettivologicici 171
Indagini semeiologiche nelle uveiti infantili 169
Heidelberg retina tomograph in the follow-up of papilledema 169
Patologie dell'uvea 166
Successful use of canakinumab in a patient with resistant Behçet's disease 165
null 165
Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations 163
Patologie della sclera 162
Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet's Disease 160
Otticopatia ischemica anteriore (O.I.A.) e lesioni ischemiche cerebrali 156
Bilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis. 154
Significato del dosaggio del Retinolo e del Beta- Carotene in alcuni quadri di patologia oculare 153
Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy 151
Enhanced expression and function of the P2X7 purinergic receptor in peripheral blood mononuclear cells from patients with Behcet's disease 147
The pain in optic neuritis: A manifestation of visceralis hyperalgesia [Il dolore nelle neuriti ottiche: una manifestazione di iperalgesia viscerale] 133
null 133
Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis 132
null 131
Human Herpesvirus 6B active infection associated with recurrent bilteral optic neuritis 130
null 122
Il dolore nelle cheratopatie e nelle lesioni dell’epitelio corneale 120
null 120
Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease 118
null 115
null 113
null 107
Update on the Medical Management of Gastrointestinal Behçet's Disease 95
Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study 95
Interleukin-1 blockade in neuro-Behçet's disease: a case-based reflection 73
Totale 15.729
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.344
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.344
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022756 0 0 55 72 52 13 48 30 53 108 108 217
2022/20231.253 81 112 190 163 114 262 17 91 131 24 34 34
2023/20241.000 42 16 84 39 46 355 320 12 1 15 4 66
2024/20251.878 31 93 182 104 257 110 90 109 113 74 223 492
2025/20264.475 349 646 575 462 755 158 524 136 147 226 133 364
2026/2027567 231 128 208 0 0 0 0 0 0 0 0 0
Totale 15.729